© 2020 MJH Life Sciences and Contagion Live. All rights reserved.
© 2020 MJH Life Sciences™ and Contagion Live. All rights reserved.
March 31, 2020
After the MODIFY trial, investigators wanted to explore how bezlotoxumab treated patients in the real world.
March 05, 2020
An electronic alert that aids in diagnostic stewardship may be helpful in reducing inappropriate testing for C diff, according to a new study.
February 27, 2020
Using enteral vancomycin for C diff prophylaxis may be the key to reducing morbidity and improving outcomes in pediatric and young adult recipients of HSCT.
February 24, 2020
Patients who had OUD and sepsis were found to be younger and healthier than patients without OUD.
February 19, 2020
System hospitals are proactive in reducing incidence of C diff infections and CLABSIs, according to study in JAMA Network Open.
The new C diff strain may turn out to be particularly severe and requires sufficient monitoring.
February 12, 2020
In a scenario where health care preparedness is key, what are the best strategies for US hospitals to pursue?
February 07, 2020
Treatment with bezlotoxumab resulted in a statistically significant reduction of recurrent C diff in cancer patients, according to a new study.
January 09, 2020
Some asymptomatic carriers of C diff went on to have clinical infection themselves within a 6-month period.
January 07, 2020
Earlier initiation of DAP-CPT combination therapy may be beneficial, despite a tendency to use the therapy after initial treatment failure.